Michael Gelband’s Cantel Medical Corporation CMD Stock Holding History

Michael Gelband’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,737	Closed	-$458K	–	3053
2021 Q1	$458K	Sell	5,737 -7,910	-58%	-$618K	0.01%	1429
2020 Q4	$1.08M	Buy	13,647 +8,314	+156%	+$488K	0.01%	817
2020 Q3	$234K	Sell	5,333 -5,044	-49%	-$249K	﹤0.01%	1405
2020 Q2	$459K	Buy	+10,377	New	+$387K	0.01%	1125
2020 Q1	–	Sell	-4,076	Closed	-$289K	–	1851
2019 Q4	$289K	Sell	4,076 -6,495	-61%	-$471K	0.01%	1160
2019 Q3	$791K	Buy	+10,571	New	+$896K	0.03%	472

Michael Gelband's CMD Position: Q2 2021 in Review

Michael Gelband sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 5,737 shares — an estimated $458K sold.

Michael Gelband first reported a position in CMD in Q3 2019 and held it in 6 quarters. The position peaked at $1.08M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Michael Gelband reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Michael Gelband sold 5,737 Cantel Medical Corporation shares in Q2 2021, an estimated $458K.
Michael Gelband first reported a position in Cantel Medical Corporation in Q3 2019 and held it in 6 quarters.
Michael Gelband's Cantel Medical Corporation position peaked at $1.08M in Q4 2020.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.